Archive for the ‘lung cancer’ Category

Can Lung Cancer Remain Hidden for 20 Years?

Wednesday, October 15th, 2014

logo1267406_md

A new study published in Science concluded that lung cancer can be dormant for over 20 years before becoming abn aggressive for of cancer. Studying 7 patients who were smokers, never smokers, and ex-smokers they found that after the first genetic mistake that caused the cancer it could exist undetected for many years until new additional faults trigger rapid growth of the disease. Their goal is to improve detection and reduce the devastating effect of lung cancer. The researcher says ” Survival from lung cancer remains devastatingly low with many new targeted treatments making a linited impact 8on the disease. By understanding how it develops we’re opening up the diseases evolutionary ruolwe book in the hope that we can start to predict its next steps.”  New information about smoking and lung cancer was also uncovered and many of the early genetic faults are caused by smoking. However, as the disease progresses these become less important with the majority of faults caused by a new process generating mutations within the tumor controlled by a protein called APOBEC. The researcher said “This fascinating research highlights the need to find better ways to detect lung cancer earlier when it’s still following just one evolutionary path,  If we can nip the disease in the bud and treat it before it has started traveling down different evolutionary routes we could make a real difference in helping more people survive the disease.” More research is planned.

Can Components in Celery Kill Lung Cancer Cells?

Wednesday, October 8th, 2014

logo1267406_md

A new study published in PubMed concluded that celery killed up to 86 percent of lung cancer cells in vitro. It has also been found effective in killing ovarian, pancreatic, prostate, breast. and liver cancer cells because of the anticancer compound called apigenin. Researchers found that by eating just two medium stalks of celery two or three times a week they could reduce the risk of lung cancer by 60%. However, researchers are not sure if results are due to the apigenin or if it works in coperation with other compounds found in celery. They also said “Apigenin widely inhibits cell proliferation of vartious lung cancer cell lines in a dose-dependent manner and the combination treatment of apigenin and antitumor drugsis very effective in human lung cancer cells, and Nrf2-ARE pathwaymay contribute to the mechanism.” In previous studies they found  “an inverse relationship between vegetable and fruit intake and lung cancer risk in both strata of current and never smokers.” Found also were women who ate plenty of apigenin in their diets were more likely to reduce the risk of developing breast cancer by 1%. and ovarian cancer by 20%. It is believed that apigenin may work by reducing the possibility of cancerous tumors growtrh by decreasing the vascular endothelial and decreasing the glucose uptake–minimizing the cycle of cancer cell formation in the pancreas. the researchers encourage everyone to eat celery but caution people to eat organic because celery is ofter drenched with pesticides.

 

Dr Ben Johnson (skin care) and Dr Carl O Helvie (lung cancer) on Holistic Health Show.

Sunday, July 6th, 2014

ben_headshot

Dr Ben Johnson has 17 pending patents and is founder and formulator of Osmosis Pur Medical SkinCare. More information was presented earlier on this site and can be found at:  http://www.osmosisskincare.com

 

chelvie4b

Dr Carl O Helvie has 60 years experience as a nurse practitioner, educator, author and researcher and has published 8 books and chapters in 4 additional ones. He currently hosts the Holistic Health Show. More information is available at: http://www.HolisticHealthShow.com  and  http://www.BeatLungCancer.net

 

Enjoy the Interview Below:

 

Is the Timing of the First Cigarette of the Day Associated with Lung Cancer Risk?

Friday, June 27th, 2014

logo1267406_md

A new study published in the Journal of the National Cancer Institute concluded that the timing of the first cigarette of the day may be associated with getting lung cancer in both heavy and light smokers. This factor may be added to standard markers of nicotine dependence that include cigarettes smoked daily, duration of smoking, and cumulative exposure (pack years). Researchers analyzed data on 3249 ever smokers of which 1812 were lung cancer patients.  Those without lung cancer in the sample served as controls and were matched by residence, sex, and age. . The research question was “How soon after you wake up do you usually smoke your first cigarette of the day?” Responses were categorized as: 5 or fewer, 6 to 30 minutes, 31 to 60 minutes and more than 60 minutes. After controlling for smoking intensity, duration and other cancer risk factors, the cancer risk was significantly higher for those who had their first cigarette within a shorter time of rising when compared to those who smoked their first cigarette after 1 hour. This relationship held for both light and heavy smokers, and for current and past smokers but not different between men and women. Researchers concluded that although the data support a signicantly higher risk of lung cancer for those who smoke sooner upon arising there is need for more research to validate these findings.

 

Can a Breathalyzer Sample Detect Lung Cancer?

Wednesday, June 25th, 2014

logo1267406_md

A new study presented recently at the American Society of Clinical Oncology conference in Chicago concluded that anew brethalyzer using a NaNose nanotech chip  may accurately detect lung cancer and identify the stage of progression. .The breathanalyzer is based upon the knowledge that lung cancer tumors produce chemicals called volatile organic compounds (VOC) that easily evapotate into air and produce a discernible scent.  The study included 358 patients who were either diagnosed with or at risk for lung cancer. The device accurately distinguished healthy people from  those with early stage lung cancer 85 percent of the time, and healthy people from those with advanced stage lung cancer 82 percent of the time. The test also accurately distinguished those with early from late stage lung cancer 79 percent of the time. The researchers hope the test will allow lung cancer patients to be diagnosed with a non-invasive procedure and a Boston Based company , Alpha Szenszor, has liscenbced the technology and plans to introduce it to the market within the next few years.

Does the Length of a Cigarette Influence Your Risk of Lung Cancer?

Wednesday, November 6th, 2013

logo1267406_md

A new study reported from the Harvard School of Public Health concluded that smokers of long or ultralong cigarettes are at greater risk for lung and oral cancer than smokers of regular and king-sized cigarettes. They said “We found that smokers of long or ultralong cigarettes have higher concentrations of tobacco specific carcinogens in their urine than smokers of regular or king-sized cigarettes.”

Using data from the National Health and Nutrition Examination Survey from 2007 to 2010 the urine tests of 3,600 smokers of regular, king-sized, long or ultralong cigarettes were compared, Fifty three percent of the smokers used king sized cigarettes whereas smokers of long and ultra-long cigarettes comprised 31.5 percent and smokers of regular sized cigarettes comprised 15.4 percent  of the sample. There was significantly higher levels of NNAL, an indicator of tobacco specific carcinogen, in the urine of those smoking long or ultralong cigarettes than those smoking regular or king-sized cigarettes. They also found that older smokers, non-Hispanic blacks, and females had a greater tendency to smoke long or ultralong cigarettes. Researchers concluded that “This study indicates that there is an added risk to those smoking long or ultralong cigarettes.”

 

 

Can a Simple Blood Test Diagnose Cancer?

Friday, October 25th, 2013

logo1267406_mdA new study presented at the Anesthesiology 2013 annual meeting reported that a simple blood test can detect early stage lung and prostate cancers as well as their recurrences. They said serum-free fatty acids and their metabolites can be used as screening biomarkers to help diagnose early stages of cancer and to identify the probability of recovery and recurrence after tumor removal.

The researchers looked at blood samples from 56 patients with lung cancer and 40 with prostate cancer and compared them to blood samples from people without cancer. In addition, blood was examined from from 24 patients scheduled for curative lung cancer surgery, and again six and 24 hours after surgery. The cancer patients has one-to six-times greater concentrations of serum-free fatty acids and their metabolites (biomarkers) in the blood thank patients without cancer. In the surgical group the serum free fatty acids and concentrations decreased by three to 10 times within 24 hours after the tumors were removed. The researchers said “In this study, we identified compounds that appear to be new screening biomarkers in cancer diagnosis and progress.” The head of research said “This is an exciting first step to having an uncomplicated way to detect early stages of lung, prostate and perhaps other cancers.”  It could also be used to measure the success of tumor resection surgery, immediately after surgery and long-term for recurrence screening.?”

Longest Lung Cancer Survivor Used Vitamin B17 (laetrile) and Other Natural Interventions

Wednesday, September 18th, 2013

chelvie4b

Below you will find the video presentation  from the 41st annual convention of the Cancer Control Society a couple weeks ago in which I discuss the natural interventions used when diagnosed with lung cancer 39 years ago. These included such interventions as laetrile, pancreatic enzymes, therapeutic doses of vitamin and minerals, herbs, a vegan type diet, prayer, meditation, affirmations, visualization, serving others, and other holistic interventions. I also discussed the ways I have remain cancer free and healthy over the past 37 years since recovery from cancer, and the value of a holistic approach.

Enjoy.
http://www.youtube.com/watch?v=e–GXwBFjdI

Can a Common Virus be Linked to Lung Cancer?

Friday, April 19th, 2013

logo1267406_md

 

Researchers p[resenting at the American Association of Cancer Research (AACR) Annual Meeting this month concluded that a common virus known to cause cervical and head and neck cancers may also cause some cases of lung cancer. After examining tissue samples from lung cancer patients researchers found that  nearly 6% seemed to have been driven by a strain of human papilloma virus (HPV)  Researchers examined 36 tissue samples from people diagnosed with non-small cell lung cancer who had never smoked.  Non-smokers were chosen because because smoking is a major cause of lung cancer but the causes in non-smokers is less well understood. They found that 4 of the 36 samples had signs of infection from two strains of HPV that were known to cause cancer–16 and 18. When looking more closely at the two samples infected by HPV they found that the virus had integrated into the tumor’s DNA–suggesting more strongly that the infection caused the tumor. Further research is needed to confirm the results seen in this sample.

Does the Combination of Asbestos Exposure, Asbestosis, and Smoking Increase the Risk of Lung Cancer?

Wednesday, April 17th, 2013

logo1267406_mdIn an online publication of The American Thoracic Society’s American Journal of Respiratory and Critical Care medicine researchers concluded that the chances of developing lung cancer associated with exposure to asbestos, asbestosis, and smoking are dramatically increased when these three risk factors are combined, and smoking cessation significantly reduces the risk of developing lung cancer after long term asbestos exposure. Researchers said “In our study of a large cohort of asbestos-exposed insulators and more than 50,000 non-exposed controls, we found that each individual risk factor was associated with increased risk of developing lung cancer, while the combination of all three risk factors increased the risk of developing lung cancer almost 37-fold.” Results showed that in non-smokers asbestos exposure increased the risk of dying from lung cancer 5.2 fold, while the combination of smoking and asbestos exposure increased the death rate more than 28-fold and asbestosis increased the risk of developing lung cancer among asbestos-exposed subjects in both smokers and non-smokers, with the death rate from lung cancer increasing 36.8-fold among asbestos-exposed smokers with asbestosis. In addition, among insulators who quit smoking, lung cancer rates dropped in the ten years following smoking cessation from 177 deaths per 10,000 among current smokers to 90 per 10,000  among those who quit. The lung cancer rates among those who quit more than 30 years earlier were similar to those who never smoked.